MA41818A - Timbre à micro-aiguilles pour administration d'un principe actif à la peau - Google Patents

Timbre à micro-aiguilles pour administration d'un principe actif à la peau

Info

Publication number
MA41818A
MA41818A MA041818A MA41818A MA41818A MA 41818 A MA41818 A MA 41818A MA 041818 A MA041818 A MA 041818A MA 41818 A MA41818 A MA 41818A MA 41818 A MA41818 A MA 41818A
Authority
MA
Morocco
Prior art keywords
administration
skin
micro
active substance
needle stamp
Prior art date
Application number
MA041818A
Other languages
English (en)
Inventor
Abina Crean
Karen Margrethe Engell
André Huss Eriksson
Jörgen Jansson
Anne Moore
Kim Troensegaard Nielsen
Caroline O'sullivan
Karsten Petersson
Sonja Vucen
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of MA41818A publication Critical patent/MA41818A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046—Solid microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053—Methods for producing microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA041818A 2015-03-27 2016-03-15 Timbre à micro-aiguilles pour administration d'un principe actif à la peau MA41818A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15161262 2015-03-27
EP15176101 2015-07-09

Publications (1)

Publication Number Publication Date
MA41818A true MA41818A (fr) 2018-01-30

Family

ID=55910913

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041818A MA41818A (fr) 2015-03-27 2016-03-15 Timbre à micro-aiguilles pour administration d'un principe actif à la peau

Country Status (20)

Country Link
US (2) US20180078498A1 (fr)
EP (1) EP3273942B1 (fr)
JP (1) JP6929784B2 (fr)
KR (1) KR20170131642A (fr)
CN (1) CN107405301B (fr)
AU (1) AU2016239277B2 (fr)
BR (1) BR112017020511A2 (fr)
CA (1) CA2979435A1 (fr)
DK (1) DK3273942T3 (fr)
ES (1) ES2886129T3 (fr)
HK (1) HK1246208A1 (fr)
IL (1) IL254183A0 (fr)
MA (1) MA41818A (fr)
MX (1) MX382471B (fr)
MY (1) MY191513A (fr)
PL (1) PL3273942T3 (fr)
SG (1) SG11201707141TA (fr)
UA (1) UA124141C2 (fr)
WO (1) WO2016155891A1 (fr)
ZA (2) ZA201706259B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015164840A1 (fr) 2014-04-24 2015-10-29 Georgia Tech Research Corporation Micro-aiguilles et leurs procédés de fabrication
US10940301B2 (en) 2015-04-17 2021-03-09 Georgia Tech Research Corporation Drug delivery devices having separable microneedles
WO2017209774A1 (fr) * 2016-06-03 2017-12-07 Sanova Bioscience Inc Timbre à micro-aiguilles contenant de l'acide hyaluronique à usage cosmétique
KR102401856B1 (ko) * 2017-02-17 2022-05-26 알레간 인코포레이티드 활성 성분을 갖는 마이크로니들 어레이
CN118846360A (zh) 2017-10-11 2024-10-29 乔治亚州技术研究公司 用于持续释放药物的可分离微针阵列
SG10201800072YA (en) * 2018-01-03 2019-08-27 Micropoint Tech Pte Ltd Microneedle Patches Comprising Corticosteroid
KR102094744B1 (ko) * 2018-01-26 2020-03-30 가천대학교 산학협력단 마이크로 니들 및 이의 제조방법
US11045187B2 (en) 2018-02-28 2021-06-29 BandGrip, Inc. Subcutaneous wound closure assembly and method of use
US20210145984A1 (en) * 2018-04-13 2021-05-20 North Carolina State University Ros-responsive microneedle patch for acne vulgaris treatment
KR102146704B1 (ko) * 2018-04-13 2020-08-21 가천대학교 산학협력단 사이클로스포린 A (CsA) 경피 및 피내 약물전달용 마이크로구조체
JP2021522978A (ja) 2018-05-18 2021-09-02 ポステック アカデミー−インダストリー ファンデーション 経皮透過型薬物伝達パッチおよびその製造方法
JP7487181B2 (ja) * 2018-05-18 2024-05-20 ポステック アカデミー－インダストリー ファンデーション 経皮透過型薬物伝達パッチの製造方法
CN108721204A (zh) * 2018-06-04 2018-11-02 南京紫源康医药科技有限公司 一种可溶性紫草素微针贴片及其制备方法
CN108703895B (zh) * 2018-08-21 2021-02-09 广州香蒲兰电子商务有限公司 一种深层渗透的长效保湿凝胶及制备方法
CN110917176B (zh) * 2018-08-31 2021-03-30 中科微针（北京）科技有限公司 一种可植入型缓释微针贴片及其制备方法
CN110870846A (zh) * 2018-08-31 2020-03-10 中科微针（北京）科技有限公司 一种可快速植入型缓释微针贴片及其制备方法
CN108888577B (zh) * 2018-09-11 2021-09-14 无锡元旭生物技术有限公司 一种可溶性玻尿酸美容微针贴及其制备方法
CN112752590A (zh) * 2018-09-24 2021-05-04 欧莱雅 包含用于皮肤原位反应的微针的装置
JP7666887B2 (ja) * 2018-12-21 2025-04-22 ロレアル マイクロニードルシートを使用するキット及び美容方法
GB201908229D0 (en) 2019-06-10 2019-07-24 Univ College Cork National Univ Of Ireland Microneedles and methods for the manufacture thereof
CA3144036C (fr) 2019-07-10 2023-09-26 Mineed Technology Company Limited Micro-aiguille pouvant se dissoudre
US20220401715A1 (en) 2019-10-22 2022-12-22 Georgia Tech Research Corporation Methods For Making Microneedles Using Adjustment Of Component Solubility In Casting Formulations
US20230073125A1 (en) * 2019-10-29 2023-03-09 The Regents Of The University Of California Periodontal micropatch and uses thereof
IL293214A (en) 2019-11-22 2022-07-01 Veradermics Incorporated Microneedle patch for immunostimulatory drug delivery
US20230015942A1 (en) * 2019-12-11 2023-01-19 The Regents Of The University Of California Microneedle delivery device with detachable hybrid microneedle depots for localized delivery of cells
JP2023523952A (ja) 2020-04-28 2023-06-08 ティコナ・エルエルシー マイクロニードルアセンブリ
NL2026264B1 (en) 2020-08-13 2022-04-13 Versailles B V Microneedle applicator with active ingredient for treatment of skin lesions
HU231600B1 (hu) 2020-09-18 2025-03-28 Semmelweis Egyetem 40% Bőrtapasz a SARS-CoV-2 vírusfertőzöttség elleni immunvédettség celluláris diagnosztikai vizsgálatához
CN112294750B (zh) * 2020-10-29 2023-06-20 广东药科大学 一种吲哚美辛胶束复合微针及其制备方法
CN112516449B (zh) * 2020-12-03 2023-02-21 昆明理工大学 一种可溶性微针阵列及其制备方法
IL307205A (en) * 2021-03-23 2023-11-01 Veradermics Incorporated Perilesional treatment of skin conditions
KR102778469B1 (ko) * 2021-04-12 2025-03-11 한미약품 주식회사 마이크로니들 어레이 및 이의 제조방법
WO2022246184A1 (fr) * 2021-05-21 2022-11-24 Veradermics Incorporated Timbre à micro-aiguilles pour administration de médicament immunostimulant
CN115581659A (zh) * 2021-07-05 2023-01-10 刘野 一种非甾体类抗炎药微针及其制备方法
WO2023014375A1 (fr) * 2021-08-06 2023-02-09 Lean Life Sciences, Inc Peptides cosmétiques pour améliorer le rajeunissement de la peau
KR20230129639A (ko) * 2022-03-02 2023-09-11 연세대학교 산학협력단 이중작용 pde5 억제제/질산유기에스터의 국소 혈류 증진을 위한 경피 투약 형태
WO2023194999A1 (fr) * 2022-04-07 2023-10-12 Sheba Impact Ltd. Micro-aiguilles biodégradables flexibles
WO2023218230A1 (fr) * 2022-05-13 2023-11-16 Mineed Technology Company Limited Timbre à micro-aiguilles solubles
CN115317439A (zh) * 2022-07-18 2022-11-11 合肥博思科创医药科技有限公司 一种克立硼罗微针贴剂及其制备方法
CN116115552B (zh) * 2023-01-06 2025-01-17 山东第二医科大学 一种托法替布纳米微针制剂及其制备方法和应用
WO2024262953A1 (fr) * 2023-06-21 2024-12-26 서석배 Timbre à aiguille pour injection de médicament à l'aide d'un laser
CN117883362A (zh) * 2024-01-17 2024-04-16 中国医学科学院生物医学工程研究所 一种装载富马酸二甲酯的调节性t细胞外泌体微针及其制备方法与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763426A (en) 1993-01-15 1998-06-09 Leo Pharmaceutical Products Ltd. Crystalline form of a vitamin D analogue
CA2370565C (fr) * 1999-04-23 2008-11-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Compositions pharmaceutiques contenant de la vitamine d pour application cutanee
CA2425315C (fr) 2000-10-13 2010-01-12 Alza Corporation Dispositif et procede permettant la perforation de la peau au moyen de microprotuberances
EP1345646A2 (fr) 2000-12-14 2003-09-24 Georgia Tech Research Corporation Appareils a microaiguilles et fabrication
US6893431B2 (en) * 2001-10-15 2005-05-17 Scimed Life Systems, Inc. Medical device for delivering patches
CN101102809B (zh) * 2004-11-18 2010-05-26 3M创新有限公司 涂敷微针阵列的遮蔽方法
US7651946B2 (en) 2005-12-12 2010-01-26 University College Cork - National University Of Ireland, Cork Wet etch processing
CN1857730B (zh) * 2006-03-30 2010-05-12 西安交通大学 带微孔的多腔体可降解植入式药物控释载体及其制备工艺
US20090182306A1 (en) * 2006-07-21 2009-07-16 Georgia Tech Research Corporation Microneedle Devices and Methods of Drug Delivery or Fluid Withdrawal
EP2121111B1 (fr) 2007-01-22 2018-03-14 Corium International, Inc. Applicateurs pour micro-aiguilles
US20100233194A1 (en) * 2007-03-30 2010-09-16 Jean-Philippe Combal Treatment of neovascular ocular disease states
WO2008130587A2 (fr) * 2007-04-16 2008-10-30 Corium International, Inc. Réseaux de micro-aiguilles coulées dans un solvant contenant un actif
AU2014200648B2 (en) * 2007-04-16 2015-09-24 Corium Pharma Solutions, Inc. Solvent-cast microneedle arrays containing active
JP5902390B2 (ja) * 2008-12-26 2016-04-13 久光製薬株式会社 マイクロニードルデバイス
EP2566501B1 (fr) * 2010-05-04 2019-03-13 Corium International, Inc. Méthode et dispositif permettant l'administration transdermique d'hormone parathyroïdienne au moyen d'un réseau de microprojections
GB201019577D0 (en) * 2010-11-18 2010-12-29 Univ Cork Method
GB201107642D0 (en) 2011-05-09 2011-06-22 Univ Cork Method
CN104027324B (zh) * 2013-03-06 2017-12-15 中国科学院理化技术研究所 一种可溶性微针疫苗贴片及其制备方法
MX380204B (es) * 2013-03-15 2025-03-12 Corium Inc Micrordenamiento para suministro de agente terapeútico y métodos de uso.
WO2015016235A1 (fr) * 2013-07-30 2015-02-05 Ａｓｔｉ株式会社 Réseau de microaiguilles et procédé de fabrication de réseau de microaiguilles
US20150057505A1 (en) * 2013-08-22 2015-02-26 Elwha Llc Method for Administering a Medicament to a Fetus

Also Published As

Publication number Publication date
CA2979435A1 (fr) 2016-10-06
DK3273942T3 (da) 2021-09-13
JP2018510170A (ja) 2018-04-12
KR20170131642A (ko) 2017-11-29
MX2017012321A (es) 2018-01-18
MX382471B (es) 2025-03-13
RU2017134576A (ru) 2019-04-04
US20230404909A1 (en) 2023-12-21
PL3273942T3 (pl) 2021-12-06
HK1246208A1 (zh) 2018-09-07
JP6929784B2 (ja) 2021-09-01
SG11201707141TA (en) 2017-10-30
RU2017134576A3 (fr) 2019-08-27
AU2016239277B2 (en) 2019-01-24
ZA201806163B (en) 2019-12-18
AU2016239277A1 (en) 2017-09-28
MY191513A (en) 2022-06-28
IL254183A0 (en) 2017-10-31
EP3273942A1 (fr) 2018-01-31
UA124141C2 (uk) 2021-07-28
CN107405301A (zh) 2017-11-28
WO2016155891A1 (fr) 2016-10-06
ES2886129T3 (es) 2021-12-16
EP3273942B1 (fr) 2021-06-16
CN107405301B (zh) 2021-11-30
ZA201706259B (en) 2018-12-19
BR112017020511A2 (pt) 2018-07-10
US20180078498A1 (en) 2018-03-22

Similar Documents

Publication Publication Date Title
MA41818A (fr) Timbre à micro-aiguilles pour administration d'un principe actif à la peau
EP3359241A4 (fr) Formulations d'analogues de pthrp, timbres transdermiques de celles-ci, et utilisations de celles-ci
PT3383363T (pt) Formulações farmacêuticas tópicas para o tratamento de afeções relacionadas com inflamações
FR3007969B1 (fr) Distributeur d'une dose unitaire d'une substance active sous une forme galenique solide
EP3302275A4 (fr) Indication d'états physiologiques selon la sudation
IL250239A0 (en) Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient
EP3256149A4 (fr) Formulations pour administration orale d'agents actifs
HUE039864T2 (hu) Gyógyászati készítmények CFTR-közvetítette betegségek kezelésére
IL247722A0 (en) Pharmaceutical compositions of therapeutically active compounds for treating hematolugic cancer
EP2868667A4 (fr) Agent thérapeutique à base d'anticorps anti-bmp9 en tant que principe actif, pour le traitement de l'anémie, notamment une anémie rénale et une anémie liée à un cancer
MA49141A (fr) Composés pyrrolopyridine-aniline destinés au traitement d'affections de la peau
EP3324925A4 (fr) Formulations topiques pour la peau
EP3003285A4 (fr) Forme dosifiée pharmaceutique solide de libération d'au moins un principe pharmaceutique actif dans la cavité buccale
EP3009426A4 (fr) Dérivé de 4-alcynylimidazole et médicament le comprenant en tant que principe actif
CL2015002933A1 (es) Identificación de la respuesta del paciente a la administración de un modulador del receptor s1p.
EP2956149A4 (fr) Compositions pharmaceutiques destinées au traitement d'helicobacter pylori
MA51822A (fr) Extraction d'acides alcanoïques
EP3405151A4 (fr) Administration transdermique améliorée d'agents actifs
EP2974749A4 (fr) Dispositif de génération d'ingrédient actif
PL3424499T3 (pl) Kompozycja farmaceutyczna do leczenia bólu neuropatycznego
MA40781A (fr) Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
EP2871187A4 (fr) Nouveau composé ou sel pharmaceutiquement acceptable de celui-ci, et composition pharmaceutique le contenant à titre de principe actif
EP2986333A4 (fr) Appareil médical d'application sur la peau
CL2015001881A1 (es) Compuesto 4-hidroxi-2-metil-5-(propan-2-iliden)ciclohexil-3-en-1-carbaldehido; uso del compuesto para el tratamiento de la enfermedad de alzheimer; composición farmacéutica; método para preparar la composición.
EP3371176A4 (fr) Analogues d'épothilone, procédés de synthèse, procédés de traitement, et conjugués médicamenteux de ceux-ci